Skip to main content

Shelter Pharma Ltd. (SHELTER.BO)

Bombay Stock Exchange (India) Healthcare Medical - PharmaceuticalsView data quality →
64.2Fair

ValueMarkers Composite Index

Top 92%#3,776 of 44,722
Undervalued

83% below intrinsic value ($2)

UndervaluedFair ValueOvervalued
Piotroski
3/9
Weak
Beneish
-2.44
Low Risk
Altman
7.10
Safe
DCF Value
$2
Undervalued
ROIC
7.3%
Low
P/E
9.9
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Shelter Pharma Ltd. (SHELTER.BO) — VMCI valuation read

Shelter Pharma Ltd. (SHELTER.BO) carries a VMCI composite of 64/100, 14 points above the Healthcare sector median of 50. Among mid-cap names, that gap places SHELTER.BO in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The SHELTER.BO insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads SHELTER.BO trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 3.2x is the binding constraint on the bear case, the line to track on Shelter Pharma Ltd.'s next 10-Q.

SHELTER.BO rose 1.3% over the trailing 7 days, with a +5.1% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.